Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > Will VM increase PP again?

<< Previous

Bullboard Posts

Next >>

Comment by whitenorth72on Jan 16, 2023 7:05pm

128 Views

Post# 35226778

RE:RE:RE:Will VM increase PP again?

I see the management as a shareholder that has vested interest in keeping the dilution to a minimum. Like Bigdawg said, they have bills to pay so it's inevitable that moves have to be made to keep this project in motion. Keeping a healthy float looks way better when shopping for debt financing.
I will be sticking around for that first dividend and that's when I know we made it.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?